CRBP (Corbus Pharmaceuticals Holdings) FFO


CRBP Corbus Pharmaceuticals Holdings Inc CRBP
31 GF Score
Price $8.69
! 1 Warning Sign
View Full Analysis

What is Corbus Pharmaceuticals Holdings FFO?

FFO (Funds from operations) only applies to REITs.

CRBP
31GF Score
Corbus Pharmaceuticals Holdings Inc CRBP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Corbus Pharmaceuticals Holdings Business Description

Other Exchanges 0SZI:UK3371:Germany
Address 500 River Ridge Drive, Norwood, MA, USA, 02062
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
31GF Score

Get the complete analysis for CRBP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.69
Price